Introduction
Over the next ten years the Alzheimer's disease market will become increasingly competitive as potentially disease modifying drugs vie for approval. Companies will need to scrutinize their plans to ensure implementation of appropriate launch strategies, achieving clear positioning and differentiation in a changing environment. What is right for launch in 2005 may not be effective at a later date.
Scope
Epidemiology of Alzheimer's Disease across the 7 major markets, as well as analysis of the main unmet needs in the current treatment of the disease
Overview of drugs in Phase III, II, I and pre-clinical development, plus analysis of key companies involved in the R&D pipeline: Pfizer, Lilly & Sanofi
Comprehensive analysis of key late-stage products phenserine, Alzhemed, PBT-1 and Colostrinin, with Datamonitor forecasts of drug revenues to 2014
Insight into innovative early stage products, including vaccines, as well as analysis of key research impacts concerning beta-amyloid
Highlights
Marketed products only provide temporary partial symptomatic relief: disease modification and prevention are major unmet needs. Opinion leaders consider phenserine (Axonyx) and Alzhemed (Neurochem) to have potential for successful disease modification which could challenge Aricept's market domination if supported by sufficient marketing strength.
Physicians and sections of the pharmaceutical industry are searching for options to prevent Alzheimer's disease. The large number of mechanisms contributing to the etiology and progression of the disorder add complications. There is substantial opportunity but the industry will need to carefully consider the challenges of a prophylactic market.
An increasing focus on disease prevention and early identification highlights a need for simple diagnostic tools and biological markers. Identification of 'at risk' and early clinical groups would aid trial design and assist patient segmentation and product positioning strategies, key factors as more players enter the market
Reasons to Purchase
Enhance your sales forecasting ability and future product positioning through identification of market drivers and key competitors
Optimize your knowledge of company strategies in the AD market
Identify areas of the market that are not being targeted by competitors and gain an objective view of potential in-licensing opportunities
(0 items)
